News

February 10, 2015

Contract Manufacturing Facility

Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility Cost-effective, high-quality production of API using microbial expression systems   Boonton, […]
December 9, 2014

Formulation Technology

Enteris BioPharma’s Formulation Technology Enables Oral Delivery of Cara Therapeutics’ CR845 Peptide for Acute and Chronic Pain in Phase 1a / 1b Trial   BOONTON, N.J., Dec. […]
July 17, 2014

Oral Peptide Delivery Technology

Enteris BioPharma Oral Peptide Delivery Technology Enables Key Clinical Milestone for Acute and Chronic Pain Drug Cara Therapeutics Initiates Further Phase 1a/1b Trial of Enteris’ Tablet […]
January 10, 2014

Biotech Showcase

Enteris BioPharma to Present at Biotech Showcase™ 2014   Boonton, NJ – January 9, 2014 – Enteris BioPharma, Inc., an industry leader in innovative oral dosage […]
December 3, 2013

Scientific Advisory Board

Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs Esteemed Scientific and Thought Leaders – Steven J. […]
September 30, 2013

Nordic BioScience

Enteris BioPharma and Nordic BioScience’s KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris’ Proprietary Oral Drug Delivery and Manufacturing Platform Companies to Partner […]
August 22, 2013

Timothy J. Saxon

Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand “Peptelligence® Partnering” Program Enteris Seeks to Enhance Current Feasibility-to-Licensing Strategy with Partnerships Targeting […]

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE